Skip to content
Screener

Veracyte VCYT Total Operating Expenses

Total Operating Expenses at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$168.3M+3.1%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$32.25M+8.4%
NeoGenomics logo
NeoGenomicsNEO
$101.65M-18.6%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$56.11M+16.6%
Quanterix Corporation logo
Quanterix CorporationQTRX
$56.93M+38.2%

Segments

By product

See full
Intangible asset amortization - operating expenses$579K-6.9%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$3.71B+97.6%
Enterprise value$3.48B+104%
P/E42.2×-29.1×
P/S6.9×+2.9×

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0×0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: Veracyte’s 10-K, filed February 25, 2019. Open the filing →

Filed
Feb 25, 2019, 4:52 PM EST
Fiscal year
FY2018
Accession
0001384101-19-000010

FAQ

What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.